ClinicalTrials.Veeva

Menu
V

Via Libre | Lima, Peru

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Islatravir
MK-8527-011
nucleoside
ISL
MK-8591
Lenacapavir
MK-8527
Apricitabine
Doravirine

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 13 total trials
Locations recently updated

A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)

Researchers are looking for new medicines to prevent HIV-1 (Human Immunodeficiency Virus Type 1) infection.The goals of this study are to learn:* If...

Enrolling
HIV Pre-Exposure Prophylaxis
Human Immunodeficiency Virus (HIV)
Drug: Placebo to MK-8527
Drug: MK-8527

The goal of this study is to evaluate the efficacy of the study drugs, lenacapavir (LEN) in preventing HIV infection, in participants ≥ 16 years of a...

Active, not recruiting
Pre-Exposure Prophylaxis of HIV Infection
Drug: Sub-cutaneous (SC) Lenacapavir (LEN)
Drug: PTM Oral LEN

Trial sponsors

Merck Sharp & Dohme (MSD) logo
Fred Hutchinson Cancer Center (FHCC) logo
A
Gilead Sciences logo
National Institute of Allergy and Infectious Diseases (NIAID) logo
University of Minnesota (UMN) logo
K
N
U

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems